Showing results (1541-1550 of 1,866) with videos related to

Sort By:
Pageof 187
Iscience|October 29, 2021
MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancerRebecca Caeser, Christopher Hulton, Emily Costa, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritisJonathan Aldridge, Anna-Carin Lundell, Kerstin Andersson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low ToxicityKathryn M Tully, Salomon Tendler, Lukas M Carter, et al.
Biomaterials|March 17, 2012
Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulationBenedikt Weber, Maximilian Y Emmert, Luc Behr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable AlterationsSiddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancerM Catherine Pietanza, Anya M Litvak, Anna M Varghese, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and CarbapenemasesMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Cancer Discovery|November 6, 2023
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung AdenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2017
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung CancerKathryn C Arbour, Emmett Jordan, Hyunjae Ryan Kim, et al.
The New England Journal of Medicine|April 1, 1999
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies, W Andiman, Y Bryson, et al.
Pageof 187